TNF-related apoptosis-inducing ligand: Signalling of a 'smart' molecule

被引:25
作者
Manzo, Fabio [1 ,2 ]
Nebbioso, Angela [1 ]
Miceli, Marco [1 ]
Conte, Mariarosaria [1 ]
De Bellis, Floriana [1 ,2 ]
Carafa, Vincenzo [1 ]
Franci, Gianluigi [1 ]
Tambaro, Francesco P. [3 ,4 ]
Altucci, Lucia [1 ]
机构
[1] Univ Naples 2, Dipartimento Patol Gen, Naples, Italy
[2] Dept Canc Biol, IGBMC, F-67404 Illkirch Graffenstaden, France
[3] Univ Naples 2, Dipartimento Flaviano Magrassi, Naples, Italy
[4] Osped Antonio Cardarelli, Sez Ematol, Naples, Italy
关键词
TRAIL; Cancer; Apoptosis; Signalling; Receptors; NF-KAPPA-B; CELL-DEATH; TUMOR-CELLS; TRAIL; RECEPTOR; APO2L/TRAIL; INHIBITION; SENSITIVITY; EXPRESSION; HEAT-SHOCK-PROTEIN-90;
D O I
10.1016/j.biocel.2007.12.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the tumor necrosis factor super-family and signals via two death receptors, TRAIL-R1 and TRAIL-R2, and two decoy receptors, TRAIL-R3 and TRAIL-R4, differently expressed in normal and cancer cells. TRAIL is mainly studied for its capacity to induce apoptosis preferentially in cancer cells. TRAIL is expressed in a variety of human tissues, in particular in the lymphoid system, suggesting a strong physiological role in the innate immunity. This review will focus on TRAIL gene structure and regulation, protein folding, tissue expression and molecular signalling. Finally, the potential use of TRAIL as anticancer treatment alone or in combination therapy as well as the use of drugs which signal via TRAIL and its receptors will be analyzed. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:460 / 466
页数:7
相关论文
共 34 条
[1]   Safety and antitumor activity of recombinant soluble Apo2 ligand [J].
Ashkenazi, A ;
Pai, RC ;
Fong, S ;
Leung, S ;
Lawrence, DA ;
Masters, SA ;
Blackie, C ;
Chang, L ;
McMurtrey, AE ;
Hebert, A ;
DeForge, L ;
Koumenis, IL ;
Lewis, D ;
Harris, L ;
Bussiere, J ;
Koeppen, H ;
Shahrokh, Z ;
Schwall, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :155-162
[2]   Disruption of NF-κB signaling reveals a novel role for NF-κB in the regulation of TNF-related apoptosis-inducing ligand expression [J].
Baetu, TM ;
Kwon, H ;
Sharma, S ;
Grandvaux, N ;
Hiscott, J .
JOURNAL OF IMMUNOLOGY, 2001, 167 (06) :3164-3173
[3]   PROTEIN DATA BANK - COMPUTER-BASED ARCHIVAL FILE FOR MACROMOLECULAR STRUCTURES [J].
BERNSTEIN, FC ;
KOETZLE, TF ;
WILLIAMS, GJB ;
MEYER, EF ;
BRICE, MD ;
RODGERS, JR ;
KENNARD, O ;
SHIMANOUCHI, T ;
TASUMI, M .
JOURNAL OF MOLECULAR BIOLOGY, 1977, 112 (03) :535-542
[4]   Cysteine 230 is essential for the structure and activity of the cytotoxic ligand TRAIL [J].
Bodmer, JL ;
Meier, P ;
Tschopp, J ;
Schneider, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (27) :20632-20637
[5]   Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice [J].
Cretney, E ;
Takeda, K ;
Yagita, H ;
Glaccum, M ;
Peschon, JJ ;
Smyth, MJ .
JOURNAL OF IMMUNOLOGY, 2002, 168 (03) :1356-1361
[6]   TNF-related apoptosis-inducing ligand as a therapeutic agent in autoimmunity and cancer [J].
Cretney, E ;
Shanker, A ;
Yagita, H ;
Smyth, MJ ;
Sayers, TJ .
IMMUNOLOGY AND CELL BIOLOGY, 2006, 84 (01) :87-98
[7]   Histone deacetylase inhibitors modulate the sensitivity of tumor necrosis factor-related apoptosis-inducing ligand-resistant bladder tumor cells [J].
Earel, JK ;
VanOosten, RL ;
Griffith, TS .
CANCER RESEARCH, 2006, 66 (01) :499-507
[8]   Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death [J].
Georgakis, GV ;
Li, Y ;
Rassidakis, GZ ;
Martinez-Valdez, H ;
Medeiros, LJ ;
Younes, A .
CLINICAL CANCER RESEARCH, 2006, 12 (02) :584-590
[9]   Genomic organization and transcriptional regulation of human Apo2/TRAIL gene [J].
Gong, B ;
Almasan, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 278 (03) :747-752
[10]   Developmental pathways that generate natural-killer-cell diversity in mice and humans [J].
Huntington, Nicholas D. ;
Vosshenrich, Christian A. J. ;
Di Santo, James P. .
NATURE REVIEWS IMMUNOLOGY, 2007, 7 (09) :703-714